Speech Sound Stimulation for Language Disorder
Trial Summary
What is the purpose of this trial?
The purpose of this study is to better understand cortical contributions of the human temporal lobe to the frequency-following response. Frequency-following responses (FFR) are electrophysiological recordings that reflect phase-locked activity of neural ensembles in the auditory pathway and are used as an indicator of the integrity of supra-threshold speech processing. FFR was first studied in subcortical areas, but recent consensus in the literature supports the notion that it is an integrated response between subcortical and cortical neural populations. The proposed study aims to deconstruct the role of the cortex in generating and modulating the FFR. The research team will build a novel computational model of FFR mechanisms and use EEG recordings from participants who have undergone resection of lesions in Heschl's gyrus to validate model predictions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Speech sound stimulation, Speech sound therapy, Speech sound treatment, Auditory feedback therapy for language disorder?
Research on similar treatments, like the integrated SSD treatment program PhonoSens and ultrasound visual feedback, shows promise in improving speech sound disorders by focusing on phonological and phonetic processing and using visual feedback to aid learning. These approaches suggest that targeted sound therapies can be effective in addressing speech sound issues.12345
Is speech sound stimulation therapy safe for humans?
How does the Speech Sound Stimulation treatment for language disorder differ from other treatments?
The Speech Sound Stimulation treatment is unique because it focuses on enhancing the brain's ability to process sounds, potentially improving speech through neuronal plasticity (the brain's ability to change and adapt) in the auditory pathway. This approach may differ from traditional speech therapies that primarily focus on practicing sound production without directly targeting the brain's auditory processing capabilities.38101112
Research Team
Taylor Abel, MD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for individuals aged 13-25 with normal nonverbal IQ, vision, language skills, and hearing. They must be monolingual English speakers undergoing surgery for a lesion in Heschl's gyrus without autism or ADHD history.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
sEEG-EEG Recording Sessions
Participants undergo sEEG-EEG recording sessions to measure pitch decoding accuracy, frequency-following response magnitude, and phase-locking limits
Follow-up
Participants are monitored for predictability effects of cortical resection on pitch decoding accuracy and frequency-following response magnitude
Treatment Details
Interventions
- Speech sound stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator